Pragya’s ambition is to integrate cutting-edge biochemical research with practical dermatological applications, enabling Granlab® to design therapies and solutions that are both effective and accessible. Ultimately, her goal is to advance equity of access within the skin health sector, ensuring that patients across diverse backgrounds benefit from next-generation dermatological care.

Dr Sharma’s academic and professional journey to date provide a strong foundation for success for Granlab®. With a PhD in structural biochemistry, she has extensive research expertise in drug target identification, protein overexpression, molecular simulations, and cellular and molecular biology methods. Her entrepreneurial accolades include Ireland’s 30 under 30 for Leadership and Innovation in Biotech, NHS Clinical Entrepreneur, and Young Businesswoman of the Year 2023. These reflect both scientific excellence and leadership in translating research into impact. In addition, Pragya’s experience in patent law as a trainee patent attorney at Hanna IP had equipped her with a unique perspective on safeguarding innovation in a competitive healthcare environment.

At Granlab®, Pragya is leading a multidisciplinary team enriched by specialist contractors and advisors with expertise in dermatology, clinical trial management, and commercialisation.

Together, Pragya and her team are building not only innovative technologies, but also a culture of inclusivity, compassion, and scientific rigor. By pursuing a PgDip in Dermatology in Clinical Practice, she continues to enhance her ability to guide the team with clinical authority, ensuring Granlab® research and innovations align directly with patient and clinician needs.